Literature DB >> 6610752

Auto-anti-anti-DNA antibodies from SLE patients and normals.

O Taniguchi, D S Chia, E V Barnett.   

Abstract

Cross reacting auto-anti-idiotypic antibodies against anti-ssDNA antibodies were investigated in patients with systemic lupus erythematosus (SLE) and normals. Sera or immunoglobulins from SLE and normals depleted of anti-ssDNA activity and DNA antigen inhibited the reaction between 125I-F(ab')2 anti-ssDNA and ssDNA. In addition, binding to F(ab')2 portions of chromatographically purified portions of anti-ssDNA coated on polystyrene wells could be measured both in depleted SLE and normal sera. Depleted sera from SLE had both greater inhibitory activity and more antibody binding capacity than depleted sera from normals. IgG from SLE sera bound to both F(ab')2 anti-ssDNA and SLE F(ab')2 non-anti-ssDNA. However, the binding of IgG to F(ab')2 anti-ssDNA was significantly inhibited by ssDNA. These results indicate that cross reacting auto-anti-anti-ssDNA as well as other antibodies to F(ab')2 portions of homologous IgG are found in higher concentration in SLE than in normals.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6610752

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  10 in total

1.  Idiotypic mimicry of a cell surface DNA receptor: evidence for anti-DNA antibodies being a subset of anti-anti-DNA receptor antibodies.

Authors:  R M Bennett; K A Cornell; M J Merritt; A C Bakke; D Mourich; S H Hefeneider
Journal:  Clin Exp Immunol       Date:  1992-12       Impact factor: 4.330

Review 2.  Protective role of anti-idiotypic antibodies in autoimmunity--lessons for type 1 diabetes.

Authors:  Christiane S Hampe
Journal:  Autoimmunity       Date:  2012-02-23       Impact factor: 2.815

3.  Relationship between naturally occurring human antibodies to casein and autologous antiidiotypic antibodies: implications for the network theory.

Authors:  C Cunningham-Rundles; Z K Feng; Z Zhou; K R Woods
Journal:  J Clin Immunol       Date:  1991-09       Impact factor: 8.317

Review 4.  The idiotype-antiidiotype network in human autoimmunity.

Authors:  N I Abdou
Journal:  J Clin Immunol       Date:  1985-11       Impact factor: 8.317

5.  Antiidiotypic antibodies against anti-DNA antibodies in sera of families of lupus patients.

Authors:  N I Abdou; R Suenaga; M Hatfield; M Evans; K M Hassanein
Journal:  J Clin Immunol       Date:  1989-01       Impact factor: 8.317

6.  Anti-idiotypic antibody against anti-DNA in sera of laboratory personnel exposed to lupus sera or nucleic acids.

Authors:  M Hatfield; M Evans; R Suenaga; K M Hassanein; N I Abdou
Journal:  Clin Exp Immunol       Date:  1987-10       Impact factor: 4.330

7.  An idiotope-specific autoantibody in SLE.

Authors:  C G Mackworth-Young; R S Schwartz
Journal:  Clin Exp Immunol       Date:  1988-01       Impact factor: 4.330

8.  The lack of anti-idiotypic antibodies, not the presence of the corresponding autoantibodies to glutamate decarboxylase, defines type 1 diabetes.

Authors:  Shilpa Oak; Lisa K Gilliam; Mona Landin-Olsson; Carina Törn; Ingrid Kockum; Christina R Pennington; Merrill J Rowley; Michael R Christie; J Paul Banga; Christiane S Hampe
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-26       Impact factor: 11.205

9.  Anti-idiotypes against anti-neutrophil cytoplasmic antigen autoantibodies in normal human polyspecific IgG for therapeutic use and in the remission sera of patients with systemic vasculitis.

Authors:  F Rossi; D R Jayne; C M Lockwood; M D Kazatchkine
Journal:  Clin Exp Immunol       Date:  1991-02       Impact factor: 4.330

10.  Anti-idiotypic antibody specific to GAD65 autoantibody prevents type 1 diabetes in the NOD mouse.

Authors:  Xin Wang; Aixia Zhang; Yu Liu; Shi Chen; Zhenqing Feng; Wenbin Shang; Marlena Maziarz; Jared Radtke; Christiane S Hampe
Journal:  PLoS One       Date:  2012-02-24       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.